Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent brain metastases Company to host webinar on Tuesday, ...
technologynetworks

Bio-Rad Announces new Human Primary Cell Transfection Protocols

Bio-Rad Laboratories, Inc. has announced 12 new protocols for electroporation of human primary cells and primary cell lines. The cells include T-cells, neutrophils, and several B-cell lymphomas. The ...
FOX8 Cleveland

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent ...